provider portal
Wesper Journal
Wesper is poised to change sleep medicine alongside GLP-1 by integrating advanced sleep monitoring technology with GLP-1 therapies, enabling comprehensive and personalized treatment for sleep apnea. This combination offers real-time treatment optimization and enhanced patient outcomes, marking a significant advancement...
Continue reading
GLP-1 Receptor Agonists and Obstructive Sleep Apnea (OSA): A New Era in Sleep Health ManagementThe approval of GLP-1 receptor agonists, such as Zepbound (tirzepatide), represents a groundbreaking development in the treatment of Obstructive Sleep Apnea (OSA). These medications not only...
Continue reading
In a landmark move, the FDA approved Zepbound (tirzepatide), the first GLP-1-based medication for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity, offering hope beyond traditional CPAP therapy. It works by activating GLP-1 and GIP hormone...
Continue reading
 Insomnia disrupts the brain's emotion regulation, leading to heightened emotional responses and intensified OCD cycles. Sleeplessness amplifies stress, intrusive thoughts, and compulsive behaviors, complicating recovery and emotional stability. Sleepless Nights and Emotional Overdrive How Restlessness Fuels OCD Cycles When...
Continue reading
Many individuals with ADHD also experience sleep apnea, which exacerbates ADHD symptoms but can be significantly alleviated through CPAP therapy and lifestyle modifications. Personal stories highlight the transformative impact of treatment, leading to improved focus, energy, and overall well-being. 1....
Continue reading